Clinical Trials
When traditional treatments don't give the results you seek, research-based medical treatments may offer hope. Many OU Physicians conduct research at the University of Oklahoma Health Sciences Center. In many cases, we can provide state-of-the-art care through national clinical trials. Following are a few examples of our expertise:
OU Physicians ranks among the top centers in the country in the number of National Cancer Institute-endorsed treatments for women's cancers, providing more of the newest innovations than any center in the state.
- OU Physicians is a national leader in research in developing minimally invasive, laparoscopic surgeries to eliminate uterine cancer.
- Our surgical oncologist was awarded first prize for the Outstanding Research Project of 2000 from The American College of Obstetricians and Gynecologists (ACOG) for his refinements of ductal lavage.
- We are the only group in the state doing research specifically directed toward effective treatment of pancreatic cancer.
- Our board-certified, fellowship-trained, pediatric urologists pioneered urological tissue engineering to create functional bladders.
- Our otolaryngologists are pioneering the use of gene therapy for the treatment of head and neck cancers.
- Our hematology-oncology department is involved in more clinical trials than any other hematology-oncology specialists in the state.
- The Peggy and Charles Stephenson Cancer Center offers more Phase I clinical trials than any other group or hospital in Oklahoma. As the state's only comprehensive academic cancer center, and home to the TSET Phase I Clinical Trials program, we offer potentially lifesaving resources not available elsewhere in Oklahoma for people battling cancer.
- An OU Physician manages the nation's only registry of pregnancies exposed to cancer chemotherapy.
- Children at the OU Children's Diabetes Center were among the first in the world ever to receive inhaled insulin, which is being developed as a substitute to insulin shots. Recently, the center was awarded a National Institutes of Health grant to develop optimal treatment for children and adolescents diagnosed with type 2 diabetes. This project addresses the emerging epidemic of type 2 diabetes in young people throughout the nation.